Nucleai
Noga Yerushalmi serves as the Investment Director and Head of the Israel Bio-incubator at M Ventures since January 2018, alongside roles as Head of PMatX since February 2019 and a Consultant for Life Sciences since January 2017. With extensive experience in various leadership positions, Yerushalmi was Co-Founder of DYNOVLY LTD, Director of Business Development at FutuRx, VP of R&D at miCure Therapeutics, and Senior Director of Cancer Drug Discovery at Rosetta Genomics. Yerushalmi's educational background includes a postdoctoral fellowship in Molecular Biology at NCI-NIH and a PhD in Biochemistry from Tel Aviv University. Additionally, foundational studies in Biology occurred at Tel Aviv University.
This person is not in the org chart
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.